TRANSCAT INC (TRNS) Fundamental Analysis & Valuation

NASDAQ:TRNS • US8935291075

Current stock price

70.21 USD
-1.54 (-2.15%)
At close:
70.21 USD
0 (0%)
After Hours:

This TRNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. TRNS Profitability Analysis

1.1 Basic Checks

  • In the past year TRNS was profitable.
  • In the past year TRNS had a positive cash flow from operations.
  • In the past 5 years TRNS has always been profitable.
  • Each year in the past 5 years TRNS had a positive operating cash flow.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • TRNS's Return On Assets of 1.67% is in line compared to the rest of the industry. TRNS outperforms 43.75% of its industry peers.
  • TRNS's Return On Equity of 2.66% is in line compared to the rest of the industry. TRNS outperforms 43.75% of its industry peers.
  • TRNS's Return On Invested Capital of 3.14% is in line compared to the rest of the industry. TRNS outperforms 41.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TRNS is below the industry average of 9.03%.
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROIC 3.14%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.47%, TRNS is in line with its industry, outperforming 47.92% of the companies in the same industry.
  • TRNS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of TRNS (5.60%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of TRNS has grown nicely.
  • The Gross Margin of TRNS (32.45%) is better than 64.58% of its industry peers.
  • TRNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. TRNS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRNS is destroying value.
  • Compared to 1 year ago, TRNS has more shares outstanding
  • TRNS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, TRNS has a worse debt to assets ratio.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • TRNS has an Altman-Z score of 3.43. This indicates that TRNS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.43, TRNS is in the better half of the industry, outperforming 64.58% of the companies in the same industry.
  • TRNS has a debt to FCF ratio of 4.02. This is a neutral value as TRNS would need 4.02 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.02, TRNS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.34 indicates that TRNS is not too dependend on debt financing.
  • TRNS has a Debt to Equity ratio of 0.34. This is in the better half of the industry: TRNS outperforms 60.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Altman-Z 3.43
ROIC/WACC0.35
WACC8.89%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • TRNS has a Current Ratio of 2.21. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of TRNS (2.21) is better than 60.42% of its industry peers.
  • A Quick Ratio of 1.85 indicates that TRNS should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.85, TRNS is doing good in the industry, outperforming 79.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.85
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRNS Growth Analysis

3.1 Past

  • TRNS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.19%.
  • The Earnings Per Share has been growing slightly by 6.36% on average over the past years.
  • Looking at the last year, TRNS shows a quite strong growth in Revenue. The Revenue has grown by 17.45% in the last year.
  • TRNS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.97% yearly.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%

3.2 Future

  • Based on estimates for the next years, TRNS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.15% on average per year.
  • The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y28.71%
EPS Next 2Y25.5%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. TRNS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 41.79, which means the current valuation is very expensive for TRNS.
  • TRNS's Price/Earnings ratio is a bit more expensive when compared to the industry. TRNS is more expensive than 60.42% of the companies in the same industry.
  • TRNS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.23.
  • The Price/Forward Earnings ratio is 30.32, which means the current valuation is very expensive for TRNS.
  • TRNS's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.28. TRNS is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 41.79
Fwd PE 30.32
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TRNS is on the same level as its industry peers.
  • TRNS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TRNS is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.34
EV/EBITDA 17.58
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • TRNS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TRNS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as TRNS's earnings are expected to grow with 17.45% in the coming years.
PEG (NY)1.46
PEG (5Y)6.57
EPS Next 2Y25.5%
EPS Next 3Y17.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRNS Dividend Analysis

5.1 Amount

  • No dividends for TRNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRNS Fundamentals: All Metrics, Ratios and Statistics

TRANSCAT INC

NASDAQ:TRNS (3/20/2026, 8:25:46 PM)

After market: 70.21 0 (0%)

70.21

-1.54 (-2.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners96.34%
Inst Owner Change0.55%
Ins Owners0.98%
Ins Owner Change0%
Market Cap655.06M
Revenue(TTM)319.69M
Net Income(TTM)7.89M
Analysts80
Price Target103.36 (47.22%)
Short Float %4.8%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.05%
Min EPS beat(2)-23.53%
Max EPS beat(2)-14.58%
EPS beat(4)2
Avg EPS beat(4)2.74%
Min EPS beat(4)-23.53%
Max EPS beat(4)46.44%
EPS beat(8)4
Avg EPS beat(8)4.49%
EPS beat(12)7
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)2
Avg Revenue beat(2)0.8%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.01%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.56%
Revenue beat(12)6
Avg Revenue beat(12)-1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)-2.25%
PT rev (3m)-2.25%
EPS NQ rev (1m)0.75%
EPS NQ rev (3m)-14.23%
EPS NY rev (1m)-4.87%
EPS NY rev (3m)-12.5%
Revenue NQ rev (1m)1.14%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)1.52%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 41.79
Fwd PE 30.32
P/S 2.05
P/FCF 26.34
P/OCF 16.68
P/B 2.21
P/tB N/A
EV/EBITDA 17.58
EPS(TTM)1.68
EY2.39%
EPS(NY)2.32
Fwd EY3.3%
FCF(TTM)2.67
FCFY3.8%
OCF(TTM)4.21
OCFY6%
SpS34.26
BVpS31.81
TBVpS-0.29
PEG (NY)1.46
PEG (5Y)6.57
Graham Number34.67
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROCE 4.1%
ROIC 3.14%
ROICexc 3.17%
ROICexgc 10.29%
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
FCFM 7.78%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Debt/EBITDA 2.34
Cap/Depr 57.97%
Cap/Sales 4.51%
Interest Coverage 250
Cash Conversion 91.87%
Profit Quality 315.12%
Current Ratio 2.21
Quick Ratio 1.85
Altman-Z 3.43
F-Score4
WACC8.89%
ROIC/WACC0.35
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y28.71%
EPS Next 2Y25.5%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%
EBIT growth 1Y-18.8%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year192.7%
EBIT Next 3Y47.62%
EBIT Next 5Y32.49%
FCF growth 1Y34.44%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y31.51%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS Fundamental Analysis FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 4 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 2 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 41.79 and the Price/Book (PB) ratio is 2.21.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 5 / 10.